Briefs: Relonchem, Patel Chem Specialities and J & H Pharma Consultants

Relonchem receives marketing authorization for Moxonidine tablets

Relonchem receives marketing authorization for Moxonidine tablets

Marksans Pharma Limited’s wholly owned subsidiary Relonchem Limited in UK has received marketing authorization for Moxonidine 200 microgram Tablets and Moxonidine 400 microgram Tablets from UK MHRA.

Patel Chem Specialities inks agreement with J&H Pharma Consultants

Patel Chem Specialities has executed an independent turnkey project service agreement with J & H Pharma Consultants for the Indrad plan. The total consideration of Rs 45 crore.  J & H Pharma Consultants is responsible for designing, engineering, procuring, constructing, and testing the project, and then handing it over to the Patel Chem Specialities in a fully operational condition.